RELIEF: The Changing Landscape of Axial Spondyloarthritis (axSpA): Current and Emerging Agents for Individualized Treatment

RELIEF: The Changing Landscape of Axial Spondyloarthritis (axSpA): Current and Emerging Agents for Individualized Treatment is organized by Med Learning Group.

Dates:
Release Date: Nov 22, 2019
Expiration Date: Nov 22, 2020

Accreditation:
Credit Designation Statement:
Med Learning Group designates this online activity for a maximum of 1.5 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nursing Credit Information:
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with axial spondyloarthritis.
CNE Credits: 1.5 ANCC Contact Hours.

Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing. Awarded 1.5 contact hour(s) of continuing nursing education of RNs and APNs.

Description:
This case-based enduring activity will cover the treatment and management of patients with axial spondyloarthritis.

Objectives:
After completing the CME activity, learners should be better able to:
• Examine the specific domains of axial spondyloarthritis (axSpA) and their relationship to quality of life
• Review current and emerging therapies used for axSpA
• Evaluate the IL-17/23 axis and its relationship to the pathophysiology of axSpA
• Compare outcomes measures used in clinical trials versus those that may be more practical for use in clinical practice

Additional details will be posted as soon as information is available.